Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evaxion A (EVAX) Equity Ratio (2019 - 2025)

Evaxion A posted quarterly Equity Ratio of 0.6 for Q4 2025, up 553.3% year-on-year from 0.09 in Q4 2024, and up 553.3% on a QoQ basis from 0.13 in Q4 2024.

Evaxion A (EVAX) has 7 years of Equity Ratio data on file, last reported at 0.6 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 553.3% year-over-year to 0.6; the trailing twelve-month figure through Dec 2025 stood at 0.6 (up 553.3% YoY), and the FY2025 full-year result was 0.6, up 553.3% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.6, up from 0.13 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.81 in Q4 2021 and bottomed at 0.37 in Q4 2023.
  • The 5-year median for Equity Ratio is 0.38 (2022), against an average of 0.26.
  • The widest annual swing landed in 2023, when Equity Ratio sank 197.33%; it then soared 553.3% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.81 in 2021, then sank by 53.32% to 0.38 in 2022, then plunged by 197.33% to 0.37 in 2023, then surged by 63.94% to 0.13 in 2024, then surged by 553.3% to 0.6 in 2025.
  • The last three Equity Ratio figures came in at 0.6 (Q4 2025), 0.13 (Q4 2024), and 0.37 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Revolution Medicines 32.39 Bn 32.39 Bn - 0.67

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.60
Dec 31, 2024 -0.13
Dec 31, 2023 -0.37
Dec 31, 2022 0.38
Dec 31, 2021 0.81
Dec 31, 2020 0.59
Dec 31, 2019 0.84